Akademik Veri Yönetim Sistemi
Eurasian Journal of Medical Investigation, cilt.8, sa.2, ss.98-105, 2024 (TRDizin)
Objectives: COVID-19 is a new respiratory disease that is spreading widely throughout the World. We aimed to investigate the level of anxiety and depression during COVID-19 pandemic among patients with various types of cancer. Methods: A consecutive series of cancer patients who applied to the outpatient clinic were recruited. The semistructured sociodemographic and clinical data form, The Spielberger State-Trait Anxiety Inventory(STAI), Hospital Anxiety and Depression Scale(HADS), and Wong Baker Face Scale(WBFS) were completed by all participants. An abnormal score of STAI was considered when ≥40.HADS scores below 7 are defined as “normal.” Results: 180 patients with cancer were analyzed. 62.8% of them were female. The most common cancers were breast cancer (31.1%). Patients’ mean HADS-A and HADS-D scores were 6.64±4.12 and 6.63±4.35. The HADS-A scores were significantly higher in patients who receive active chemotherapy, afraid of to be infected with COVID-19 and afraid of their families to be infected with COVID-19 (p=.013, p<0.001, p=.011, respectively). The mean STAI-T score was 44.48±8.42 and STAI-S score was 41.29± 10.29. 72.2% patients showed a STAI-T score ≥40, 55% patients showed a STAI-S score ≥40. STAI-T and STAI-S scores were significantly higher in patients who are afraid of to be infected with COVID-19 than those who are not (p= .032, p=.004, respectively). Conclusion: This study provides evidence that cancer patients have a high prevalence of anxiety and depression levels during the COVID-19 pandemic.The pandemic may have a greater effect on patients who receive active chemotherapy and all patients had significant fear about themselves and their families to be infected with COVID-19.